| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2015↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $28.4B | $26.5B | $6.4B | $22.4B | $22.4B | $5.3B | $5.4B | $4.5B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $5.6B | $5.3B | $4.9B | $4.8B | $4.8B | $4.5B | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $3.8B | $3.1B | $0.8B | $1.8B | $2.4B | $0.5B | $0.5B | $1.7B |
| EPS (Basic) | $13.51 | $10.51 | $2.55 | $5.52 | $6.71 | $1.48 | $1.51 | $1.03 |
| EPS (Diluted) | $13.32 | $10.35 | $2.51 | $5.44 | $6.62 | $1.47 | $1.49 | $1.01 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2015↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $86.0B | $80.9B | $76.8B | $73.0B | $76.6B | $74.1B | $70.8B | $228.3B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.1B | $0.2B | $0.1B | $0.2B | $0.2B | $0.2B | $0.2B | $0.4B |
| Total Liabilities | $67.0B | $64.5B | $61.5B | $59.4B | $58.7B | $55.6B | $54.5B | $210.7B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $19.0B | $16.4B | $15.3B | $13.6B | $17.8B | $18.6B | $16.3B | $17.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2015↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $5.9B | $5.9B | $4.2B | $4.0B | $4.1B | $3.9B | $3.5B | $2.8B |
| Investing Cash Flow | $-3.8B | $-3.8B | $-2.4B | $-1.3B | $-2.5B | $-2.1B | $-2.1B | $0.5B |
| Capital Expenditures | $0.2B | $0.1B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B | $0.3B |
| Financing Cash Flow | $-2.2B | $-2.1B | $-1.9B | $-2.7B | $-1.6B | $-1.8B | $-1.2B | $-3.1B |